Identification of retroviral conserved pol sequences in serum of mixed connective tissue disease and systemic sclerosis patients

Biomed Pharmacother. 2004 Jan;58(1):61-4. doi: 10.1016/j.biopha.2003.10.001.

Abstract

Human endogenous retroviruses (HERVs) expression has been suspected as a factor participating in the development of autoimmune diseases. Employing the dot blot hybridisation, we observed that 90.9% of mixed connective tissue disease (MCTD) (n = 22) patients exhibited the presence of human immunodeficiency virus type 1 (HIV-1) conserved pol sequence in DNA isolated from serum. The same investigation conducted in the group of systemic sclerosis (SSc) (n = 79) patients identified a conserved retroviral pol sequence in 34.6% of antinuclear antibodies (ANA) positive (n = 52) and 40.7% of ANA negative (n = 27) patients. However, 100% of anti-U1-ribonucleoprotein (RNP) positive SSc (n = 9) patients exhibited the presence of HIV-1 conserved pol sequence. Our findings suggest that the presence of retroviral sequence in serum of MCTD and SSc patients may correlate with development of autoimmune response directed against U1-70 kDa polypeptide antigen.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Antinuclear / blood
  • Autoantigens / immunology
  • Conserved Sequence
  • DNA Topoisomerases, Type I
  • Female
  • Gene Products, pol / blood*
  • Gene Products, pol / genetics
  • HIV-1 / enzymology*
  • HIV-1 / genetics
  • Humans
  • Male
  • Mixed Connective Tissue Disease / blood
  • Mixed Connective Tissue Disease / enzymology*
  • Mixed Connective Tissue Disease / genetics
  • Nuclear Proteins / immunology
  • Ribonucleoprotein, U1 Small Nuclear / immunology
  • Scleroderma, Systemic / blood
  • Scleroderma, Systemic / enzymology*
  • Scleroderma, Systemic / genetics

Substances

  • Antibodies, Antinuclear
  • Autoantigens
  • Gene Products, pol
  • Nuclear Proteins
  • Ribonucleoprotein, U1 Small Nuclear
  • Scl 70 antigen, human
  • DNA Topoisomerases, Type I